Literature DB >> 900151

Rickets in adult cystic fibrosis with myopathy, pancreatic insufficiency and proximal renal tubular dysfunction.

J Scott, E Elias, P J Moult, S Barnes, M R Wills.   

Abstract

Rickets is reported in a 19 year old white man with cystic fibrosis in whom pancreatic and hepatic involvement was advanced. There was evidence of secondary hyperparathyroidism with proximal renal tubular acidosis, aminoaciduria, phosphaturia and hypophosphatemia. Treatment with oral pancreatic and parenteral vitamin D supplements led to full recovery of the rachitic syndrome and the proximal renal tubular dysfunction.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 900151     DOI: 10.1016/0002-9343(77)90290-x

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  7 in total

Review 1.  The role of vitamins in cystic fibrosis.

Authors:  S B Carr; J McBratney
Journal:  J R Soc Med       Date:  2000       Impact factor: 5.344

Review 2.  Pharmacokinetics of drugs in cystic fibrosis.

Authors:  M Spino
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

3.  Why bother to take vitamins?

Authors:  Alison Morton
Journal:  J R Soc Med       Date:  2011-07       Impact factor: 5.344

4.  Vitamin status in treated patients with cystic fibrosis.

Authors:  P J Congden; G Bruce; M M Rothburn; P C Clarke; J M Littlewood; J Kelleher; M S Losowsky
Journal:  Arch Dis Child       Date:  1981-09       Impact factor: 3.791

5.  Scoliosis in cystic fibrosis--an appraisal.

Authors:  M R Paling; M Spasovsky-Chernick
Journal:  Skeletal Radiol       Date:  1982       Impact factor: 2.199

6.  Vitamin D and parathyroid hormone and bone mineralisation in adults with cystic fibrosis.

Authors:  R J Stead; S Houlder; J Agnew; M Thomas; M E Hodson; J C Batten; P Dandona
Journal:  Thorax       Date:  1988-03       Impact factor: 9.139

Review 7.  Pharmacology and therapeutic use of vitamin D and its analogues.

Authors:  A M Pierides
Journal:  Drugs       Date:  1981-04       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.